Predictors of parenchymal hematoma and clinical outcome after mechanical thrombectomy in patients with large ischemic core due to large vessel occlusion: a retrospective multicenter study.

Intervention Stroke

Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
21 Dec 2023
Historique:
received: 18 10 2023
accepted: 03 12 2023
medline: 22 12 2023
pubmed: 22 12 2023
entrez: 21 12 2023
Statut: aheadofprint

Résumé

The aim of our study was to find predictors of parenchymal hematoma (PH) and clinical outcome after mechanical thrombectomy (MT) in patients with large vessel occlusion (LVO) and baseline large infarct. The databases of 16 stroke centers were retrospectively screened for patients with anterior circulation LVO and baseline Alberta Stroke Program Early CT Score (ASPECTS) ≤5 that received MT. Procedural parameters, including the number of passes during first and second technique of MT, were recorded. Outcome measures were occurrence of PH type 2 and any type of PH after MT, and the 90-day modified Rankin Scale (mRS) score of 0-3 and 0-2. In total, 408 patients were available for analysis. A higher number of passes in the second technique was predictive of PH type 2 (odds ratio (OR) - 3.204, 95% confidence interval (CI) 1.140 to 9.005), whereas procedure conducted under general anesthesia was associated with lower risk (OR 0.127, 95% CI 0.002 to 0.808). The modified thrombolysis in cerebral infarction grade 2c-3 was associated with the mRS score 0-3 (OR 3.373, 95% CI 1.891 to 6.017), whereas occurrence of PH type 2 was predictive of unfavorable outcome (OR 0.221, 95% CI 0.063 to 0.773). Similar results were found for the mRS score 0-2 outcome measure. In patients with large ischemic core, a higher number of passes during MT and procedure not conducted under general anesthesia are associated with increased rate of PH type 2, that negatively impact the clinical outcome. Our data outline a delicate balance between the need of a complete recanalization and the risk of PH following MT.

Sections du résumé

BACKGROUND BACKGROUND
The aim of our study was to find predictors of parenchymal hematoma (PH) and clinical outcome after mechanical thrombectomy (MT) in patients with large vessel occlusion (LVO) and baseline large infarct.
METHODS METHODS
The databases of 16 stroke centers were retrospectively screened for patients with anterior circulation LVO and baseline Alberta Stroke Program Early CT Score (ASPECTS) ≤5 that received MT. Procedural parameters, including the number of passes during first and second technique of MT, were recorded. Outcome measures were occurrence of PH type 2 and any type of PH after MT, and the 90-day modified Rankin Scale (mRS) score of 0-3 and 0-2.
RESULTS RESULTS
In total, 408 patients were available for analysis. A higher number of passes in the second technique was predictive of PH type 2 (odds ratio (OR) - 3.204, 95% confidence interval (CI) 1.140 to 9.005), whereas procedure conducted under general anesthesia was associated with lower risk (OR 0.127, 95% CI 0.002 to 0.808). The modified thrombolysis in cerebral infarction grade 2c-3 was associated with the mRS score 0-3 (OR 3.373, 95% CI 1.891 to 6.017), whereas occurrence of PH type 2 was predictive of unfavorable outcome (OR 0.221, 95% CI 0.063 to 0.773). Similar results were found for the mRS score 0-2 outcome measure.
CONCLUSION CONCLUSIONS
In patients with large ischemic core, a higher number of passes during MT and procedure not conducted under general anesthesia are associated with increased rate of PH type 2, that negatively impact the clinical outcome. Our data outline a delicate balance between the need of a complete recanalization and the risk of PH following MT.

Identifiants

pubmed: 38129110
pii: jnis-2023-021146
doi: 10.1136/jnis-2023-021146
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Andrea M Alexandre (AM)

Interventional Neuroradiology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Luca Scarcia (L)

Neuroradiology Unit, Henri Mondor Hospital, Creteil, France.

Valerio Brunetti (V)

Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Irene Scala (I)

Catholic University School of Medicine, Rome, Italy.

Erwah Kalsoum (E)

Neuroradiology Unit, Henri Mondor Hospital, Creteil, France.

Iacopo Valente (I)

Interventional Neuroradiology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Arianna Camilli (A)

Catholic University School of Medicine, Rome, Italy.

Davide De Leoni (D)

Catholic University School of Medicine, Rome, Italy.

Francesca Colò (F)

Catholic University School of Medicine, Rome, Italy.

Giovanni Frisullo (G)

Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Mariangela Piano (M)

Neuroradiology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Claudia Rollo (C)

Neuroradiology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Antonio Macera (A)

Neuroradiology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Maria Ruggiero (M)

Neuroradiology Unit, Maurizio Bufalini Hospital, Cesena, Italy.

Elvis Lafe (E)

Neuroradiology Unit, Maurizio Bufalini Hospital, Cesena, Italy.

Joseph D Gabrieli (JD)

Neuroradiology Unit, Policlinico Universitario di Padova, Padua, Italy.

Giacomo Cester (G)

Neuroradiology Unit, Policlinico Universitario di Padova, Padua, Italy.

Nicola Limbucci (N)

Interventional Neurovascular Unit, A.O.U. Careggi, Florence, Italy.

Francesco Arba (F)

Stroke Unit, A.O.U. Careggi, Florence, Italy.

Simone Ferretti (S)

NEUROFARBA Department, University of Florence, Florence, Italy.

Valerio Da Ros (V)

Department of Biomedicine and Prevention, University Hospital of Rome "Tor Vergata", Rome, Italy.

Luigi Bellini (L)

Department of Biomedicine and Prevention, University Hospital of Rome "Tor Vergata", Rome, Italy.

Giancarlo Salsano (G)

Neuroradiology Unit, IRCCS Ospedale Policlinico San Martino, Genua, Italy.

Nicola Mavilio (N)

Neuroradiology Unit, IRCCS Ospedale Policlinico San Martino, Genua, Italy.

Riccardo Russo (R)

Neuroradiology Unit, A.O. Città della Salute e della Scienza, Turin, Italy.

Mauro Bergui (M)

Neuroradiology Unit, A.O. Città della Salute e della Scienza, Turin, Italy.

Antonio A Caragliano (AA)

Neuroradiology Unit, A.O.U. Policlinico G. Martino, Messina, Italy.

Sergio L Vinci (SL)

Neuroradiology Unit, A.O.U. Policlinico G. Martino, Messina, Italy.

Daniele G Romano (DG)

Neuroradiology Unit, A.O.U. S. Giovanni di Dio e Ruggi di Aragona, Salerno, Italy.

Giulia Frauenfelder (G)

Neuroradiology Unit, A.O.U. S. Giovanni di Dio e Ruggi di Aragona, Salerno, Italy.

Vittorio Semeraro (V)

Interventional Radiology Unit, "SS Annunziata" Hospital, Taranto, Italy.

Maria P Ganimede (MP)

Neuroradiology Unit, "SS Annunziata" Hospital, Taranto, Italy.

Emilio Lozupone (E)

Neuroradiology Unit, Vito Fazzi Hospital, Lecce, Italy.

Andrea Romi (A)

Neuroradiology Unit, IRCCS Policlinico San Matteo, Pavia, Italy.

Anna Cavallini (A)

Department of Emergency Neurology and Stroke Unit, IRCCS Fondazione Mondino, Rome, Italy.

Luca Milonia (L)

Interventional Neuroradiology, University Hospital Policlinico Umberto I, Rome, Italy.

Massimo Muto (M)

Neuroradiology Unit, Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli", Naples, Italy.

Flavio Giordano (F)

Neuroradiology Unit, Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli", Naples, Italy.

Luigi Cirillo (L)

Neurology and Stroke Center, IRCCS Istituto delle Scienze Neurologiche di Bologna - Maggiore Hospital, Bolona, Italy.
Dipartimento di Scienze Biomediche e Neuromotorie (DIBINEM), University of Bologna, Bologna, Italy.

Paolo Calabresi (P)

Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Catholic University School of Medicine, Rome, Italy.

Alessandro Pedicelli (A)

Interventional Neuroradiology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Catholic University School of Medicine, Rome, Italy.

Aldobrando Broccolini (A)

Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy aldobrando.broccolini@policlinicogemelli.it.
Catholic University School of Medicine, Rome, Italy.

Classifications MeSH